The development of the Diagnostic Related Group in the 80s, efforts to integrate hospitals, physicians, and managed care in the 90s, and early steps in outcomes-based reimbursement in the first... read more →
A new healthcare framework—the Quadruple Aim—seeks to transform the U.S. healthcare system, improving health outcomes, enhancing the patient experience and lowering per capita healthcare costs. Key Points: More than a... read more →
In an effort to reduce healthcare costs while improving the quality of care, healthcare stakeholders—including solo practices and even payers—are becoming increasingly integrated, giving rise to the organized customer. Key... read more →
Eyeforpharma, an organization dedicated to the exchange of best practices within the pharmaceutical industry, hosted an Early Access Masterclass Webinar featuring key insights from senior-level pharma executives. The primary objectives... read more →
The Kinetix Group (TKG) Care Delivery Services has launched a Real World Evidence (RWE) model, focusing on diabetes and cardiovascular conditions. As a part of this initiative, we have partnered... read more →
By Shane Devereux Apple and Amazon are setting themselves up to become major players in disrupting healthcare in 2018. With Apple’s recent announcement of uniting patients with their healthcare data,... read more →
Kinetix Immersions & Life Science Customer Engagement Why Immersions? The healthcare ecosystem continues to evolve, as payer, hospital, and health-system priorities and footprints continue to shift. Additionally, customer-centricity and effective... read more →
As we continue to analyze key elements of the evolving healthcare landscape, our next series of blog posts will discuss payers’ and health systems’ approaches to achieving the Quadruple Aim... read more →
This post is part of a series analyzing the impact of the changing healthcare landscape on the pharmaceutical industry. In our examination of healthcare stakeholder dynamics, it is important to consider... read more →
This post is part of a series analyzing the impact of the changing healthcare landscape on the pharmaceutical industry. In our examination of healthcare stakeholder dynamics, it is important to analyze... read more →